{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:07:35Z","timestamp":1700525255886},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"vor","delay-in-days":4154,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbiology and Immunology"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We developed a new technique for culture study that successfully recovers fungi from drug\u2010treated skin tissues, in which tissue specimens were homogenized, dialyzed against water, digested with trypsin, and then washed with PBS, to eliminate the drug that remaining in the skin tissue specimens. With this modified culture method, we reevaluated the efficacy of KP\u2010103, neticonazole, and lanoconazole in a guinea pig interdigital tinea pedis model. Guinea pigs with tinea pedis were topically treated with a 1% solution of KP\u2010103 or a reference drug once a day for 10 consecutive days. Five days after the last treatment, left and right feet were subjected to culture study by the conventional and modified recovery culture methods, respectively. One hundred percent (20\/20) of lanoconazole\u2010treated feet were judged as culture\u2010negative by the conventional culture method, but 85% (17\/20) of the feet were shown to be culture\u2010positive when the modified recovery culture method was used. On the other hand, KP\u2010103 achieved high rates of culture\u2010negative rates, 95% (19\/20) and 85% (17\/20), in both conventional and modified culture methods, respectively. Furthermore, on day\u201030 posttreatment, KP\u2010103 sterilized 14 of the 20 infected feet, whereas neticonazole and lanoconazole were not effective even in reducing fungal burden. KP\u2010103 proved to be highly effective in achieving mycological cure and preventing relapse against tinea pedis presumably because of its good bioavailability in the skin based on its low keratin\u2010affinity, along with its potent antifungal activity.<\/jats:p>","DOI":"10.1111\/j.1348-0421.2002.tb02717.x","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T15:36:55Z","timestamp":1384443415000},"page":"433-439","source":"Crossref","is-referenced-by-count":3,"title":["<i>In Vivo<\/i> Fungicidal Effect of KP\u2010103 in a Guinea Pig Model of Interdigital Tinea Pedis Determined by Using a New Method for Removing the Antimycotic Carryover Effect"],"prefix":"10.1111","volume":"46","author":[{"given":"Yoshiyuki","family":"Tatsumi","sequence":"first","affiliation":[{"name":"Central Research Laboratories Kaken Pharmaceutical Co., Ltd.  Kyoto Kyoto 607\u20108042 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Central Research Laboratories Kaken Pharmaceutical Co., Ltd.  Kyoto Kyoto 607\u20108042 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Arika","sequence":"additional","affiliation":[{"name":"Central Research Laboratories Kaken Pharmaceutical Co., Ltd.  Kyoto Kyoto 607\u20108042 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Research Center for Medical Mycology Teikyo University  Hachioji Tokyo 192\u20100352 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1128\/AAC.34.11.2250","article-title":"Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs","volume":"34","author":"Arika T.","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.11.2523"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.2.363"},{"key":"e_1_2_2_5_1","first-page":"769","article-title":"Antifungal activity of SS717, a new imidazole antimycotic. II Therapeutic effect and protective effect of pretreatment on experimental dermatophytosis in guinea pigs","volume":"38","author":"Asaoka T.","year":"1990","journal-title":"Chemotherapy (Tokyo)"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198938020-00004"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.31.333"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi1947.111.2_126"},{"key":"e_1_2_2_9_1","first-page":"146","article-title":"Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp","volume":"48","author":"Niwano Y.","year":"1995","journal-title":"Jpn. J. Antibiot."},{"key":"e_1_2_2_10_1","first-page":"1056","article-title":"Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites","volume":"47","author":"Niwano Y.","year":"1997","journal-title":"Arzneim.\u2010Forsch.\/Drug Res."},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.47.1417"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.33.313"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.3.390"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1365"},{"key":"e_1_2_2_15_1","first-page":"227","volume-title":"In vitro and in vivo evaluation of antifungal agents","author":"Takahashi H.","year":"1986"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1493-1499.2001"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2002.tb02716.x"},{"key":"e_1_2_2_18_1","first-page":"1007","article-title":"In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis","volume":"44","author":"Uchida K.","year":"1991","journal-title":"Jpn. J. Antibiot."},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.34.207"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.40.151"}],"container-title":["Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1348-0421.2002.tb02717.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1348-0421.2002.tb02717.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T19:06:41Z","timestamp":1700507201000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1348-0421.2002.tb02717.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1111\/j.1348-0421.2002.tb02717.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1348-0421.2002.tb02717.x","archive":["Portico"],"relation":{},"ISSN":["0385-5600","1348-0421"],"issn-type":[{"value":"0385-5600","type":"print"},{"value":"1348-0421","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}